Found: 94
Select item for more details and to access through your institution.
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 6, p. 1233, doi. 10.1093/jac/dkp102
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1344, doi. 10.1093/jac/dkn399
- By:
- Publication type:
- Article
Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 161, doi. 10.1093/jac/dkn187
- By:
- Publication type:
- Article
Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 5, p. 908, doi. 10.1093/jac/dki354
- By:
- Publication type:
- Article
Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100?mg once daily versus twice daily.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 4, p. 542, doi. 10.1093/jac/dki043
- By:
- Publication type:
- Article
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 3, p. 501, doi. 10.1093/jac/dkh116
- By:
- Publication type:
- Article
Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 19982000.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 3, p. 469, doi. 10.1093/jac/dkh102
- By:
- Publication type:
- Article
Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Effect of a Modified Saquinavir/Ritonavir Dosing Regimen with Lower Dose Lead-In Phase on QTc Interval, Pharmacokinetics, Antiviral Activity and Safety in Treatment-Naïve HIV-1-Infected Patients.
- Published in:
- Drugs in R&D, 2015, v. 15, n. 1, p. 141, doi. 10.1007/s40268-015-0087-7
- By:
- Publication type:
- Article
Intersecting HIV and mpox epidemics: more questions than answers.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, n. 12, p. 1, doi. 10.1002/jia2.26043
- By:
- Publication type:
- Article
The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 3, p. 1, doi. 10.1002/jia2.25468
- By:
- Publication type:
- Article
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 7, p. N.PAG, doi. 10.1002/jia2.25352
- By:
- Publication type:
- Article
Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 7, p. N.PAG, doi. 10.1002/jia2.25333
- By:
- Publication type:
- Article
In memoriam: Professor David Cooper (1949 to 2018).
- Published in:
- 2018
- By:
- Publication type:
- Obituary
The science of Durban, AIDS 2016.
- Published in:
- 2017
- By:
- Publication type:
- Proceeding
The science of Durban, AIDS 2016.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.1.21781
- By:
- Publication type:
- Article
The science of Durban, AIDS 2016.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, n. 1, p. 1, doi. 10.7448/IAS.20.1.21781
- By:
- Publication type:
- Article
Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
- Published in:
- Journal of the International AIDS Society, 2016, v. 19, n. 1, p. 1, doi. 10.7448/IAS.19.1.20504
- By:
- Publication type:
- Article
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19572
- By:
- Publication type:
- Article
Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19739
- By:
- Publication type:
- Article
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19737
- By:
- Publication type:
- Article
Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014-2018.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19497
- By:
- Publication type:
- Article
Should the dose of tenofovir be reduced to 200-250 mg/day, when combined with protease inhibitors?
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19583
- By:
- Publication type:
- Article
Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19793
- By:
- Publication type:
- Article
Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19747
- By:
- Publication type:
- Article
Large disparities in HIV treatment cascades between eight European and high-income countries - analysis of break points.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19507
- By:
- Publication type:
- Article
Management of HIV: still a long way to go.
- Published in:
- British Journal of Hospital Medicine (17508460), 2008, v. 69, n. 3, p. 126, doi. 10.12968/hmed.2008.69.3.28746
- By:
- Publication type:
- Article
Effectiveness of provider-initiated versus client-initiated HIV testing by different health facility departments in Northern Tanzania.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-023-00541-z
- By:
- Publication type:
- Article
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0285787
- By:
- Publication type:
- Article
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
- Published in:
- Nature Medicine, 2005, v. 11, n. 11, p. 1170, doi. 10.1038/nm1319
- By:
- Publication type:
- Article
Efficacy of Tenofovir Disoproxil Fumarate in Antiretroviral Therapy--Naive and --Experienced Patients Coinfected with HIV-1 and Hepatitis B Virus.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 7, p. 1185
- By:
- Publication type:
- Article
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 5, p. 1073, doi. 10.1007/s13555-022-00722-0
- By:
- Publication type:
- Article
Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087334
- By:
- Publication type:
- Article
Lower Healthcare Costs Associated with the Use of a Single-Pill ARV Regimen in the UK, 2004--2008.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047376
- By:
- Publication type:
- Article
The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996-2008.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0027830
- By:
- Publication type:
- Article
Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020200
- By:
- Publication type:
- Article
Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015677
- By:
- Publication type:
- Article
Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV-1 Vaccine Candidates.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 5, p. 720, doi. 10.1086/650492
- By:
- Publication type:
- Article
Stability in care and risk of loss to follow‐up among clients receiving community health worker‐led differentiated HIV care: Results from a prospective cohort study in northern Tanzania.
- Published in:
- Tropical Medicine & International Health, 2024, v. 29, n. 4, p. 309, doi. 10.1111/tmi.13975
- By:
- Publication type:
- Article
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI.
- Published in:
- BMC Infectious Diseases, 2011, v. 11, n. 1, p. 23, doi. 10.1186/1471-2334-11-23
- By:
- Publication type:
- Article
Multidrug-Resistant Tuberculosis and HIV Infection.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 953b, n. 1, p. 192, doi. 10.1111/j.1749-6632.2001.tb11377.x
- By:
- Publication type:
- Article
Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 68, n. 1, p. 116, doi. 10.1111/j.1365-2125.2009.03430.x
- By:
- Publication type:
- Article
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 54, doi. 10.1111/j.1365-2125.2008.03136.x
- By:
- Publication type:
- Article
An MPER antibody neutralizes HIV-1 using germline features shared among donors.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-12973-1
- By:
- Publication type:
- Article
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF
- Published in:
- Patient, 2015, v. 8, n. 4, p. 359, doi. 10.1007/s40271-015-0129-9
- By:
- Publication type:
- Article
Emtricitabine/Tenofovir Disoproxil Fumarate: A Viewpoint by Anton Pozniak.
- Published in:
- Drugs, 2004, v. 64, n. 18, p. 2083, doi. 10.2165/00003495-200464180-00007
- By:
- Publication type:
- Article
Tenofovir, Equivalence, and Noninferiority—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 16, p. 1951, doi. 10.1001/jama.292.16.1951-b
- By:
- Publication type:
- Article